Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025)

Aurora Cannabis (ACB) posted quarterly Other Non-Current Liabilities of $1.3 million for Q4 2025, down 68.71% year-on-year from $4.1 million in Q4 2024, and down 1.98% on a QoQ basis from $1.3 million in Q3 2025.

Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Other Non-Current Liabilities for 8 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 68.71% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 68.71% YoY) and the FY2025 annual result came in at $1.2 million, down 70.8% from the prior year.
  • Other Non-Current Liabilities declined to $1.3 million in Q4 2025 per ACB's latest filing, from $1.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for ACB reached as high as $4.2 million in Q2 2022 and fell as low as $502106.4 in Q1 2022.
  • A 5-year average of $2.7 million and a median of $2.9 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2021 — Other Non-Current Liabilities soared 774.11% — and 2025, when it slumped 71.71%.
  • Year by year, Other Non-Current Liabilities stood at $2.0 million in 2021, then soared by 30.46% to $2.6 million in 2022, then jumped by 48.7% to $3.8 million in 2023, then gained by 6.69% to $4.1 million in 2024, then tumbled by 68.71% to $1.3 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.3 million, $1.3 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.27 Mn
Sep 30, 2025 1.30 Mn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 1.18 Mn
Dec 31, 2024 4.07 Mn
Sep 30, 2024 4.11 Mn
Jun 30, 2024 4.24 Mn
Mar 31, 2024 4.16 Mn
Dec 31, 2023 3.81 Mn
Sep 30, 2023 3.71 Mn
Jun 30, 2023 3.50 Mn
Mar 31, 2023 3.29 Mn
Dec 31, 2022 2.56 Mn
Sep 30, 2022 3.19 Mn
Jun 30, 2022 4.24 Mn
Mar 31, 2022 502,106.36
Dec 31, 2021 1.97 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 1.69 Mn
Mar 31, 2021 1.58 Mn